Reference Pricing as a Deterrent to Entry: Evidence from the European Pharmaceutical Market
Luca Maini and
Fabio Pammolli
American Economic Journal: Microeconomics, 2023, vol. 15, issue 2, 345-83
Abstract:
External reference pricing (ERP), the practice of benchmarking domestic drug prices to foreign prices, generates an incentive for firms to withhold products from low-income countries. Using a novel moment inequality approach, we estimate a structural model to measure how ERP policies affect access to innovative drugs across Europe. We find that ERP increases entry delays in eight low-income European countries by up to one year per drug. The European Union could remove these delays without replacing ERP by compensating firms through lump-sum transfers at the cost of around €18 million per drug.
JEL-codes: L13 L51 L65 (search for similar items in EconPapers)
Date: 2023
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://www.aeaweb.org/doi/10.1257/mic.20210053 (application/pdf)
https://doi.org/10.3886/E160781V1 (text/html)
https://www.aeaweb.org/doi/10.1257/mic.20210053.appx (application/pdf)
https://www.aeaweb.org/doi/10.1257/mic.20210053.ds (application/zip)
Access to full text is restricted to AEA members and institutional subscribers.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:aea:aejmic:v:15:y:2023:i:2:p:345-83
Ordering information: This journal article can be ordered from
https://www.aeaweb.org/journals/subscriptions
DOI: 10.1257/mic.20210053
Access Statistics for this article
American Economic Journal: Microeconomics is currently edited by Johannes Hörner
More articles in American Economic Journal: Microeconomics from American Economic Association Contact information at EDIRC.
Bibliographic data for series maintained by Michael P. Albert ().